Anna Blom
261 – 270 of 325
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Contribution of interactions between complement inhibitor C4b-binding protein and pathogens to their ability to establish infection with particular emphasis on Neisseria gonorrhoeae.
(
- Contribution to journal › Article
-
Mark
Defining targets for complement components C4b and C3b on the pathogenic neisseriae
(
- Contribution to journal › Article
-
Mark
Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein in Alzheimer's disease: Binding to Abeta(1-42) and to dead cells.
(
- Contribution to journal › Article
-
Mark
Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein is present in affected areas of myocardial infarction during the acute inflammatory phase and covers a larger area than C3.
(
- Contribution to journal › Article
- 2007
-
Mark
Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals
(
- Contribution to journal › Article
-
Mark
Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistance.
(
- Contribution to journal › Article
-
Mark
The factor H variant associated with age-related macular degeneration (H384) and the non-disease associated form bind differentially to C-reactive protein, fibromodulin, DNA and necrotic cells.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein and factor h compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack
(
- Contribution to journal › Article